Degree I II and III internal hemorrhoids
Conditions
Interventions
Xiaozhiling group:Endoscopic injection of Xiaozhiling for the treatment of internal hemorrhoids+Localized skin clearing ointment and Puzi hemorrhoidal suppositories in the anus+Postoperative fumigatio
Polydocanol group:Endoscopic injection of polydocanol for the treatment of internal hemorrhoids+Localized skin clearing ointment and Puzi hemorrhoidal suppositories in the anus+Postoperative fumigatio
Sponsors
Affiliated Hospital of Traditional Chinese Medicine Southwest Medical University Luzhou City Sichuan Province
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1) The patients with grade I - III internal hemorrhoids are accompanied with symptoms related to internal hemorrhoids and conservative treatment is ineffective; 2) Age 18-80 (including patients aged 18 and 80); 3) The patient volunteered to participate in the study completed the treatment plan and cooperated with the treatment observation and signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1) Those with perianal complications such as incarcerated hemorrhoids annular mixed hemorrhoids perianal abscess anal fissure anal fistula rectal prolapse intestinal tumors and other diseases; 2) Complicated with internal hemorrhoid ligation; 3) Have received hemorrhoid surgery and sclerotherapy within half a year; 4) Allergic or allergic constitution to Xiaozhiling and polydocanol; 5) Important organs include those with serious basic diseases such as heart brain liver kidney and lung; 6) Those who have a history of mental illness and cannot cooperate with the treatment; 7) Pregnant women women during menstruation or patients receiving other treatment at the same time; 8) Those who continue to need anticoagulant treatment or have coagulation dysfunction; 9) The researchers believe that patients with factors that are not suitable to participate in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| clinical efficacy; | — |
Secondary
| Measure | Time frame |
|---|---|
| 1-year recurrence rate after surgery;EQ-5D Health Rating Scale;complication;Clinically relevant information (including length of stay hospitalization costs satisfaction); | — |
Countries
China
Contacts
Public ContactYutengjiang
Affiliated Hospital of Traditional Chinese Medicine of Southwest Medical University
Outcome results
None listed